Literature DB >> 20827223

Downregulation of miR-125b in metastatic cutaneous malignant melanoma.

Martin Glud1, Maria Rossing, Christoffer Hother, Line Holst, Nina Hastrup, Finn C Nielsen, Robert Gniadecki, Krzysztof T Drzewiecki.   

Abstract

This study aimed to identify microRNA species involved in the earliest metastatic event in cutaneous malignant melanoma (MM). Samples from 28 patients with MM [stage T2 (tumor), M0 (distant metastasis)] were grouped by the presence of micrometastasis in the sentinel lymph nodes (N0/N1). Melanoma cells were harvested from primary, cutaneous MM tumors by laser-capture microdissection, and microRNA expression profiles were obtained by the microarray technique. Results were validated by quantitative reverse transcription PCR. We found that miR-125b was downregulated in the primary cutaneous melanomas that produced early metastases (T2, N1, M0) compared with the sentinel lymph node-negative (T2, N0, M0) melanomas. MiR-125b has earlier been found to be downregulated in other tumor types and in atypic naevi compared with the common acquired naevi. In conclusion, miR-125b may be involved in an early progression of cutaneous MM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827223     DOI: 10.1097/CMR.0b013e32833e32a1

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  34 in total

1.  MicroRNA-125b potentiates macrophage activation.

Authors:  Aadel A Chaudhuri; Alex Yick-Lun So; Nikita Sinha; William S J Gibson; Konstantin D Taganov; Ryan M O'Connell; David Baltimore
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

Review 2.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

3.  Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.

Authors:  Sankhiros Babapoor; Rong Wu; James Kozubek; Donna Auidi; Jane M Grant-Kels; Soheil S Dadras
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

4.  Complementary strand microRNAs mediate acquisition of metastatic potential in colonic adenocarcinoma.

Authors:  Dung-Tsa Chen; Jonathan M Hernandez; David Shibata; Susan M McCarthy; Leigh Ann Humphries; Whalen Clark; Abul Elahi; Mike Gruidl; Domenico Coppola; Timothy Yeatman
Journal:  J Gastrointest Surg       Date:  2012-02-24       Impact factor: 3.452

Review 5.  Biochemistry of epidermal stem cells.

Authors:  Richard L Eckert; Gautam Adhikary; Sivaprakasam Balasubramanian; Ellen A Rorke; Mohan C Vemuri; Shayne E Boucher; Jackie R Bickenbach; Candace Kerr
Journal:  Biochim Biophys Acta       Date:  2012-07-20

6.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

7.  MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.

Authors:  Chengyue Zhang; Limin Shu; Ah-Ng Tony Kong
Journal:  Curr Pharmacol Rep       Date:  2015-01-11

8.  microRNA expression profiles in human colorectal cancers with brain metastases.

Authors:  Zhenyang Li; Xiaodong Gu; Yantian Fang; Jianbin Xiang; Zongyou Chen
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

9.  MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma.

Authors:  Jie Zhang; Sijia Na; Caiyue Liu; Shuting Pan; Junying Cai; Jiaxuan Qiu
Journal:  Tumour Biol       Date:  2015-11-23

Review 10.  The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites.

Authors:  Angeline A Giangreco; Larisa Nonn
Journal:  J Steroid Biochem Mol Biol       Date:  2013-01-16       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.